You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ICOS

Showing 1 - 25 of 114
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

Not yet recruiting
  • Metastatic Melanoma
  • Advanced Melanoma
  • San Francisco, California
    University of California, San Francisco
Jan 13, 2023

Cancer Related Cardiovascular Toxicity Trial in Italy, North Macedonia, Serbia (Prospective validation of the HFA-ICOS risk

Not yet recruiting
  • Cancer Related Cardiovascular Toxicity
  • Prospective validation of the HFA-ICOS risk score in a subset of subjects with newly diagnosed breast cancer and undergoing treatment with anthracyclines analogues with or without radiotherapy
  • Bologna, Italy
  • +4 more
Oct 11, 2023

Cancer Trial in Milan (Enalapril)

Active, not recruiting
  • Cancer
  • Milan, Italy
    European Institute of Oncology
Aug 12, 2021

Sarcoma Trial in United States (XmAb23104)

Recruiting
  • Sarcoma
  • XmAb23104
  • Basking Ridge, New Jersey
  • +6 more
May 18, 2023

Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Grade 1

Active, not recruiting
  • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • +18 more
  • Anti-ICOS Monoclonal Antibody MEDI-570
  • +2 more
  • Duarte, California
  • +22 more
Jan 18, 2023

Cancer Trial in United States (JTX-2011, Nivolumab, Ipilimumab)

Completed
Has Results
  • Cancer
  • Palo Alto, California
  • +15 more
Sep 5, 2021

Infertility Trial (Pharmacogenetic test)

Not yet recruiting
  • Infertility
  • Pharmacogenetic test
  • (no location specified)
Jul 14, 2020

NSCLC Trial in Worldwide (JTX-4014, Vopratelimab)

Active, not recruiting
  • NSCLC
  • Minsk, Belarus
  • +70 more
Jan 18, 2023

COVID-19 Lockdown on Psychiatric Hospital Staff and Close

Completed
  • Anxiety State
  • +3 more
  • it is a survey
  • Neuilly-sur-Marne, France
    URC Ville Evrard
Jul 31, 2020

Cancer Trial in Canada, United States (Vopratelimab, Ipilimumab)

Active, not recruiting
  • Cancer
  • Beverly Hills, California
  • +20 more
Apr 4, 2022

Understanding CARdiac Events in Breast Cancer

Recruiting
  • Breast Cancer
  • +5 more
    • Galway, Ireland
    • +3 more
    Jun 27, 2023

    Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)

    Recruiting
    • Glioblastoma Multiforme
    • Baltimore, Maryland
      Johns Hopkins Medical Institution
    Dec 5, 2022

    Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +11 more
    • New Haven, Connecticut
    • +12 more
    Nov 3, 2022

    Cancer Trial in Saint Louis, Houston (Vopratelimab, Ipilimumab, Nivolumab)

    Active, not recruiting
    • Cancer
    • Saint Louis, Missouri
    • +2 more
    Sep 9, 2022

    Mesothelioma Trial in Houston (MEDI4736, Tremelimumab, no other name)

    Active, not recruiting
    Has Results
    • Mesothelioma
    • Houston, Texas
      Baylor St Lukes
    Jan 25, 2022

    Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab

    Recruiting
    • Unresectable Melanoma
    • +3 more
    • Sargramostim (GM-CSF)
    • Pembrolizumab (anti-PD-1)
    • Boston, Massachusetts
    • +1 more
    Jul 6, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Candiolo (inulin, Pembrolizumab, Nivolumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • inulin
    • +2 more
    • Candiolo, Turin, Italy
      Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
    Apr 7, 2023

    Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma Trial in Worldwide (Aldoxorubicin, Investigator's Choice

    Completed
    • Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
    • Aldoxorubicin
    • Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide)
    • Birmingham, Alabama
    • +73 more
    Mar 28, 2022

    Lung Cancer, Non-Small Cell, Tumors Trial in Nashville, Madrid (Tumor biopsy)

    Recruiting
    • Lung Cancer, Non-Small Cell
    • Neoplasms
    • Tumor biopsy
    • Nashville, Tennessee
    • +1 more
    Aug 11, 2022

    Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

    Active, not recruiting
    • Hydronephrosis
    • +18 more
    • Durvalumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    The Significance of Release of T-follicular Helper and

    Not yet recruiting
    • Autoimmune Hemolytic Anemia
    • flowcytometry
    • (no location specified)
    Oct 22, 2021

    Human Energy Expenditure Trial in Aurora (Feasibility of measuring 2H:1H and 18O:16O in saliva and breath.)

    Enrolling by invitation
    • Human Energy Expenditure
    • Feasibility of measuring 2H:1H and 18O:16O in saliva and breath.
    • Aurora, Colorado
      Edward Melanson
    Mar 17, 2022

    Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer AJCC v7 Trial in Houston (procedure,

    Completed
    • Clear Cell Renal Cell Carcinoma
    • +2 more
    • Cryosurgery
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 6, 2022

    Recurrent Small Cell Lung Carcinoma Trial in Atlanta (Durvalumab, Hypofractionated Radiation Therapy, Stereotactic Body

    Completed
    Has Results
    • Recurrent Small Cell Lung Carcinoma
    • Durvalumab
    • +3 more
    • Atlanta, Georgia
    • +1 more
    May 28, 2021

    BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)

    Recruiting
    • Renal Cancer Metastatic
    • Immunological and tumour characterization
    • Lyon, France
      Centre Leon Berard
    Mar 14, 2022